Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer

BACKGROUND: The currently-used modes of administration of immunotherapeutic agents result in their limited delivery to the lymph nodes and/or require repetitive ultrasound-guided nodal injections or microsurgical lymphatic injections, limiting their feasibility. Here, we report on the feasibility an...

Descripción completa

Detalles Bibliográficos
Autores principales: Radomski, Michal, Zeh, Herbert J., Edington, Howard D., Pingpank, James F., Butterfield, Lisa H., Whiteside, Theresa L., Wieckowski, Eva, Bartlett, David L., Kalinski, Pawel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835859/
https://www.ncbi.nlm.nih.gov/pubmed/27096100
http://dx.doi.org/10.1186/s40425-016-0128-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835859/
https://www.ncbi.nlm.nih.gov/pubmed/27096100
http://dx.doi.org/10.1186/s40425-016-0128-y

Ejemplares similares